Literature DB >> 17468137

Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice.

Xiaoyang Hua1, Christopher J Erikson, Kelly D Chason, Craig N Rosebrock, Deepak A Deshpande, Raymond B Penn, Stephen L Tilley.   

Abstract

High levels of adenosine can be measured from the lungs of asthmatics, and it is well recognized that aerosolized 5'AMP, the precursor of adenosine, elicits robust bronchoconstriction in patients with this disease. Characterization of mice with elevated adenosine levels secondary to the loss of adenosine deaminase (ADA) expression, the primary metabolic enzyme for adenosine, further support a role for this ubiquitous mediator in the pathogenesis of asthma. To begin to identify pathways by which adenosine can alter airway tone, we examined adenosine-induced bronchoconstriction in four mouse lines, each lacking one of the receptors for this nucleoside. We show, using direct measures of airway mechanics, that adenosine can increase airway resistance and that this increase in resistance is mediated by binding the A(1) receptor. Further examination of this response using pharmacologically, surgically, and genetically manipulated mice supports a model in which adenosine-induced bronchoconstriction occurs indirectly through the activation of sensory neurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468137     DOI: 10.1152/ajplung.00058.2007

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  19 in total

1.  Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.

Authors:  Ilia Korboukh; Emily A Hull-Ryde; Joseph E Rittiner; Amarjit S Randhawa; Jennifer Coleman; Brendan J Fitzpatrick; Vincent Setola; William P Janzen; Stephen V Frye; Mark J Zylka; Jian Jin
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

2.  The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis.

Authors:  Xuebin Yang; William Walton; Donald N Cook; Xiaoyang Hua; Stephen Tilley; Christopher A Haskell; Richard Horuk; A William Blackstock; Suzanne L Kirby
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-24       Impact factor: 6.914

Review 3.  Adenosine receptors and asthma.

Authors:  R A Brown; D Spina; C P Page
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

4.  Endogenous Gs-coupled receptors in smooth muscle exhibit differential susceptibility to GRK2/3-mediated desensitization.

Authors:  Kok Choi Kong; Uma Gandhi; T J Martin; Candace B Anz; Huandong Yan; Anna M Misior; Rodolfo M Pascual; Deepak A Deshpande; Raymond B Penn
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

Review 5.  Adenosine receptors and asthma.

Authors:  Constance N Wilson; Ahmed Nadeem; Domenico Spina; Rachel Brown; Clive P Page; S Jamal Mustafa
Journal:  Handb Exp Pharmacol       Date:  2009

Review 6.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

7.  Adenosine A(1) and prostaglandin E receptor 3 receptors mediate global airway contraction after local epithelial injury.

Authors:  Jian Zhou; Martha B Alvarez-Elizondo; Elliot Botvinick; Steven C George
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-06       Impact factor: 6.914

Review 8.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

9.  Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation.

Authors:  Nathaniel A Sowa; Meagen K Voss; Mark J Zylka
Journal:  Mol Pain       Date:  2010-04-14       Impact factor: 3.395

Review 10.  Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease.

Authors:  Riccardo Polosa; Michael R Blackburn
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.